FDA Advisory Committee
September 15, 2010 — Adelphi, MD – FDA Advisory Committee on Endocrinologic and Metabolic Drugs advisory committee meeting to review the use of sibutramine in the treatment of obesity. Theodore Kyle, RPh and chair of the The Obesity Society (TOS) Advocacy Task Force, presented a statement on behalf of TOS urging the panel to balance the need for effective treatments with […]
